Literature DB >> 6412683

Antibodies to bovine liver branched-chain 2-oxo acid dehydrogenase cross-react with this enzyme complex from other tissues and species.

S C Heffelfinger, E T Sewell, D J Danner.   

Abstract

Antibodies were produced in rabbits against bovine liver branched-chain 2-oxo acid dehydrogenase (BCOAD) for three reasons. First, since activity of BCOAD varies among tissues within a species, it is necessary to ascertain whether isoenzymes exist within the different tissues. Second, it is of great interest to determine the structural similarity of BCOAD among mammalian species. Third, heritable defects of this multienzyme complex are known in humans, and techniques for studying BCOAD subunit composition in cells expressing the defect include the use of specific antibodies. Antibodies produced against BCOAD inhibit complex activity and cross-react with BCOAD from various tissues and species. By using rocket immunoelectrophoresis, the complex can be quantified in mitochondrial extracts. Each subunit is immunogenic, making the detection of subunit variants possible by the combined techniques of sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and Western blotting. Finally, antibodies produced against pig heart lipoamide dehydrogenase cross-react with BCOAD, pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes, giving further evidence for the commonality of this subunit among these three mitochondrial complexes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412683      PMCID: PMC1152133          DOI: 10.1042/bj2130339

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Leucine oxidation in rat muscle, heart, and liver homogenates.

Authors:  G L Dohm; W E Brown; H A Barakat
Journal:  Biochem Med       Date:  1976-06

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Maple syrup urine disease: coenzyme function and prenatal monitoring.

Authors:  L J Elsas; J H Priest; F B Wheeler; D J Danner; B A Pask
Journal:  Metabolism       Date:  1974-06       Impact factor: 8.694

4.  Oxidation of leucine by rat skeletal muscle.

Authors:  R Odessey; A L Goldberg
Journal:  Am J Physiol       Date:  1972-12

5.  Mammalian alpha-keto acid dehydrogenase complexes. VI. Nature of the multiple forms of pig heart lipoamide dehydrogenase.

Authors:  Y Sakurai; Y Fekuyoshi; M Hamada; T Hayakawa; M Koike
Journal:  J Biol Chem       Date:  1970-09-10       Impact factor: 5.157

6.  Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney.

Authors:  F H Pettit; S J Yeaman; L J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

8.  Inactivation of rat liver and kidney branched chain 2-oxoacid dehydrogenase complex by adenosine triphosphate.

Authors:  K S Lau; H R Fatania; P J Randle
Journal:  FEBS Lett       Date:  1981-04-06       Impact factor: 4.124

9.  Purification and characterization of branched chain alpha-ketoacid dehydrogenase from bovine liver mitochondria.

Authors:  D J Danner; S K Lemmon; J C Besharse; L J Elsas
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

10.  Leucine oxidation and protein turnover in clofibrate-induced muscle protein degradation in rats.

Authors:  H S Paul; S A Adibi
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  7 in total

1.  Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.

Authors:  Y Feng; C A Gutekunst; D E Eberhart; H Yi; S T Warren; S M Hersch
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

2.  Cloning and cDNA sequence of the dihydrolipoamide dehydrogenase component human alpha-ketoacid dehydrogenase complexes.

Authors:  G Pons; C Raefsky-Estrin; D J Carothers; R A Pepin; A A Javed; B W Jesse; M K Ganapathi; D Samols; M S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.

Authors:  H Mitsubuchi; Y Nobukuni; I Akaboshi; Y Indo; F Endo; I Matsuda
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Rat tissue concentrations of branched-chain 2-oxo acid dehydrogenase complex. Re-evaluation by immunoassay and bioassay.

Authors:  P A Patston; J Espinal; J M Shaw; P J Randle
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

5.  Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.

Authors:  Y Indo; A Kitano; F Endo; I Akaboshi; I Matsuda
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Mitochondrial import and processing of an in vitro synthesized human prebranched chain acyltransferase fragment.

Authors:  S Litwer; D J Danner
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

7.  Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.

Authors:  D J Danner; N Armstrong; S C Heffelfinger; E T Sewell; J H Priest; L J Elsas
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.